1. Home
  2. BWAY vs CBAN Comparison

BWAY vs CBAN Comparison

Compare BWAY & CBAN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BWAY
  • CBAN
  • Stock Information
  • Founded
  • BWAY 2003
  • CBAN 1975
  • Country
  • BWAY Israel
  • CBAN United States
  • Employees
  • BWAY N/A
  • CBAN N/A
  • Industry
  • BWAY Medical/Dental Instruments
  • CBAN Major Banks
  • Sector
  • BWAY Health Care
  • CBAN Finance
  • Exchange
  • BWAY Nasdaq
  • CBAN Nasdaq
  • Market Cap
  • BWAY 280.7M
  • CBAN 279.6M
  • IPO Year
  • BWAY 2019
  • CBAN 1998
  • Fundamental
  • Price
  • BWAY $15.77
  • CBAN $17.38
  • Analyst Decision
  • BWAY Strong Buy
  • CBAN
  • Analyst Count
  • BWAY 2
  • CBAN 0
  • Target Price
  • BWAY $18.00
  • CBAN N/A
  • AVG Volume (30 Days)
  • BWAY 78.9K
  • CBAN 50.1K
  • Earning Date
  • BWAY 11-11-2025
  • CBAN 10-22-2025
  • Dividend Yield
  • BWAY N/A
  • CBAN 2.63%
  • EPS Growth
  • BWAY 515.14
  • CBAN 24.13
  • EPS
  • BWAY 0.11
  • CBAN 1.57
  • Revenue
  • BWAY $46,084,000.00
  • CBAN $118,533,000.00
  • Revenue This Year
  • BWAY $339.49
  • CBAN $21.97
  • Revenue Next Year
  • BWAY $21.74
  • CBAN $27.53
  • P/E Ratio
  • BWAY $55.73
  • CBAN $11.14
  • Revenue Growth
  • BWAY 26.50
  • CBAN 8.33
  • 52 Week Low
  • BWAY $7.70
  • CBAN $13.99
  • 52 Week High
  • BWAY $16.25
  • CBAN $18.49
  • Technical
  • Relative Strength Index (RSI)
  • BWAY 67.06
  • CBAN 58.48
  • Support Level
  • BWAY $15.32
  • CBAN $16.92
  • Resistance Level
  • BWAY $16.25
  • CBAN $17.52
  • Average True Range (ATR)
  • BWAY 0.59
  • CBAN 0.34
  • MACD
  • BWAY -0.07
  • CBAN 0.03
  • Stochastic Oscillator
  • BWAY 70.25
  • CBAN 72.73

About BWAY BrainsWay Ltd.

BrainsWay Ltd is engaged in advanced noninvasive neurostimulation treatments for mental health disorders. The company is advancing neuroscience with its proprietary Deep Transcranial Magnetic Stimulation (Deep TMS) platform technology to improve health and transform lives. Current indications include depressive disorder (including reduction of anxiety symptoms, commonly referred to as anxious depression), obsessive-compulsive disorder, and smoking addiction. Additional clinical trials of Deep TMS in various psychiatric, neurological, and addiction disorders are underway. The company derives revenues from the lease and sale of Deep TMS systems.

About CBAN Colony Bankcorp Inc.

Colony Bankcorp Inc is a bank holding company. The bank provides a broad range of banking services to its retail and commercial customers. Its product line includes loans to small and medium-sized businesses, residential and commercial construction and land development loans, commercial real estate loans, agri-business and production loans, residential mortgage loans, consumer loans, and a variety of demand, savings, and time deposit products. The company's segments include the Banking Division, Retail Mortgage Division and small business specialty lending divisions. It generates maximum revenue from the Banking Division.

Share on Social Networks: